A.R.T. Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-14,338
Closed -$400K 960
2019
Q4
$400K Buy
+14,338
New +$371K 0.02% 932
2019
Q2
Sell
-34,038
Closed -$852K 1647
2019
Q1
$852K Buy
34,038
+8,760
+35% +$167K 0.05% 538
2018
Q4
$318K Buy
25,278
+1,591
+7% +$18.8K 0.02% 903
2018
Q3
$226K Buy
+23,687
New +$261K 0.01% 1149
2018
Q2
Sell
-12,270
Closed -$68K 1766
2018
Q1
$68K Sell
12,270
-1,100
-8% -$6.81K ﹤0.01% 1383
2017
Q4
$87K Buy
+13,370
New +$99.4K ﹤0.01% 1268
2015
Q1
Sell
-13,107
Closed -$126K 1709
2014
Q4
$126K Sell
13,107
-16,705
-56% -$130K ﹤0.01% 1288
2014
Q3
$290K Buy
+29,812
New +$391K 0.01% 953

Other funds holding VCYT

A.R.T. Advisors's VCYT Position: Q1 2020 in Review

A.R.T. Advisors sold out of Veracyte (VCYT) in Q1 2020, closing a stake of 14,338 shares — an estimated $400K sold.

A.R.T. Advisors first reported a position in VCYT in Q3 2014 and held it in 8 quarters. The position peaked at $852K in Q1 2019. 165 funds tracked by Wall St. Rank hold VCYT as of Q1 2020.

  • A.R.T. Advisors reported no remaining Veracyte position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 14,338 Veracyte shares in Q1 2020, an estimated $400K.
  • A.R.T. Advisors first reported a position in Veracyte in Q3 2014 and held it in 8 quarters.
  • A.R.T. Advisors's Veracyte position peaked at $852K in Q1 2019.
  • 165 funds tracked by Wall St. Rank held Veracyte as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.